Eli Lilly completes final phase of biotechnology expansion
Eli Lilly completed the final and largest phase of a major biotechnology expansion in Indianapolis, Indiana.
Eli Lilly and Company today announced that it has completed its acquisition of ImClone Systems Incorporated.